|
1
|
Becker BF: Towards the physiological
function of uric acid. Free Radic Biol Med. 14:615–631.
1993.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bardin T and Richette P: Definition of
hyperuricemia and gouty conditions. Curr Opin Rheumatol.
26:186–191. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dalbeth N, Gosling A, Gaffo A and Abhishek
A: Gout. Lancet. 397:1843–1855. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Johnson RJ, Kang DH, Feig D, Kivlighn S,
Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B,
Herrera-Acosta J and Mazzali M: Is there a pathogenetic role for
uric acid in hypertension and cardiovascular and renal disease?
Hypertension. 41:1183–1190. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Feig DI, Kang DH and Johnson RJ: Uric acid
and cardiovascular risk. N Engl J Med. 359:1811–1821.
2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lanaspa MA, Sanchez-Lozada LG, Choi YJ,
Cicerchi C, Kanbay M, Roncal-Jimenez CA, Ishimoto T, Li N, Marek G,
Duranay M, et al: Uric acid induces hepatic steatosis by generation
of mitochondrial oxidative stress: Potential role in
fructose-dependent and-independent fatty liver. J Biol Chem.
287:40732–40744. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Sautin YY, Nakagawa T, Zharikov S and
Johnson RJ: Adverse effects of the classic antioxidant uric acid in
adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am
J Physiol Cell Physiol. 293:C584–C596. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ames BN, Cathcart R, Schwiers E and
Hochstein P: Uric acid provides an antioxidant defense in humans
against oxidant- and radical-caused aging and cancer: A hypothesis.
Proc Natl Acad Sci USA. 78:6858–6862. 1981.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Peden DB, Hohman R, Brown ME, Mason RT,
Berkebile C, Fales HM and Kaliner MA: Uric acid is a major
antioxidant in human nasal airway secretions. Proc Natl Acad Sci
USA. 87:7638–7642. 1990.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sautin YY and Johnson RJ: Uric acid: The
oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids.
27:608–619. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhao G, Huang L, Song M and Song Y:
Baseline serum uric acid level as a predictor of cardiovascular
disease related mortality and all-cause mortality: A meta-analysis
of prospective studies. Atherosclerosis. 231:61–68. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang W, Iso H, Murakami Y, Miura K, Nagai
M, Sugiyama D, Ueshima H and Okamura T: EPOCH-JAPAN GROUP. Serum
uric acid and mortality form cardiovascular disease: EPOCH-JAPAN
study. J Atheroscler Thromb. 23:692–703. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lee SW, Kim HC, Nam C, Lee HY, Ahn SV, Oh
YA and Suh I: Age-differential association between serum uric acid
and incident hypertension. Hypertens Res. 42:428–437.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sakata S, Hata J, Honda T, Hirakawa Y,
Oishi E, Shibata M, Yoshida D, Goto K, Kitazono T and Ninomiya T:
Serum uric acid levels and cardiovascular mortality in a general
Japanese population: The Hisayama study. Hypertens Res. 43:560–568.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kurra V, Vehmas T, Eräranta A, Jokihaara
J, Pirttiniemi P, Ruskoaho H, Tokola H, Niemelä O, Mustonen J and
Pörsti I: Effects of oxonic acid-induced hyperuricemia on
mesenteric artery tone and cardiac load in experimental renal
insufficiency. BMC Nephrol. 16(35)2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Garcia-Arroyo FE, Gonzaga G, Munoz-Jimenez
I, Blas-Marron MG, Silverio O, Tapia E, Soto V, Ranganathan N,
Ranganathan P, Vyas U, et al: Probiotic supplements prevented
oxonic acid-induced hyperuricemia and renal damage. PLoS One.
13(e0202901)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mazzali M, Hughes J, Kim YG, Jefferson JA,
Kang DH, Gordon KL, Lan HY, Kivlighn S and Johnson RJ: Elevated
uric acid increases blood pressure in the rat by a novel
crystal-independent mechanism. Hypertension. 38:1101–1106.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yu MA, Sánchez-Lozada LG, Johnson RJ and
Kang DH: Oxidative stress with an activation of the
renin-angiotensin system in human vascular endothelial cells as a
novel mechanism of uric acid-induced endothelial dysfunction. J
Hypertens. 28:1234–1242. 2010.PubMed/NCBI
|
|
19
|
Hsu WL, Li SY, Liu JS, Huang PH, Lin SJ,
Hsu CC, Lin YP and Tarng DC: High uric acid ameliorates indoxyl
sulfate-induced endothelial dysfunction and is associated with
lower mortality among hemodialysis patients. Toxins (Basel).
9(20)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cai W, Duan XM, Liu Y, Yu J, Tang YL, Liu
ZL, Jiang S, Zhang CP, Liu JY and Xu JX: Uric acid induces
endothelial dysfunction by activating the HMGB1/RAGE signaling
pathway. Biomed Res Int. 2017(4391920)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ko J, Kang HJ, Kim DA, Kim MJ, Ryu ES, Lee
S, Ryu JH, Roncal C, Johnson RJ and Kang DH: Uric acid induced the
phenotype transition of vascular endothelial cells via induction of
oxidative stress and glycocalyx shedding. FASEB J. 33:13334–13345.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sandoo A, van Zanten JJ, Metsios GS,
Carroll D and Kitas GD: The endothelium and its role in regulating
vascular tone. Open Cardiovasc Med J. 4:302–312. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Brozovich F, Nicholson C, Degen C, Gao YZ,
Aggarwal M and Morgan K: Mechanisms of vascular smooth muscle
contraction and the basis for pharmacologic treatment of smooth
muscle disorders. Pharmacol Rev. 68:476–532. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Touyz RM, Alves-Lopes R, Rios FJ, Camargo
LL, Anagnostopoulou A, Arner A and Montezano AC: Vascular smooth
muscle contraction in hypertension. Cardiovasc Res. 114:529–539.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pacher P, Beckman JS and Liaudet L: Nitric
oxide and peroxynitrite in health and disease. Physiol Rev.
87:315–424. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Radi R: Oxygen radicals, nitric oxide, and
peroxynitrite: Redox pathways in molecular medicine. Proc Natl Acad
Sci USA. 115:5839–5848. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Maruhashi T, Hisatome I, Kihara Y and
Higashi Y: Hyperuricemia and endothelial function: From molecular
background to clinical perspectives. Atherosclerosis. 278:226–231.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yu W and Cheng JD: Uric acid and
cardiovascular disease: An update from molecular mechanism to
clinical perspective. Front Pharmacol. 11(582680)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pacher P, Obrosova IG, Mabley JG and Szabó
C: Role of nitrosative stress and peroxynitrite in the pathogenesis
of diabetic complications. Emerging new therapeutical strategies.
Curr Med Chem. 12:267–275. 2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang F, Yuan Q, Chen F, Pang J, Pan C, Xu
F and Chen Y: Fundamental mechanisms of the cell death caused by
nitrosative stress. Front Cell Dev Biol. 9(742483)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Choi YJ, Yoon Y, Lee KY, Hien TT, Kang KW,
Kim KC, Lee J, Lee MY, Lee SM, Kang DH and Lee BH: Uric acid
induces endothelial dysfunction by vascular insulin resistance
associated with the impairment of nitric oxide synthesis. FASEB J.
28:3197–3204. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mishima M, Hamada T, Maharani N, Ikeda N,
Onohara T, Notsu T, Ninomiya H, Miyazaki S, Mizuta E, Sugihara S,
et al: Effects of uric acid on the NO production of HUVECs and its
restoration by urate lowering agents. Drug Res (Stuttg).
66:270–274. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lin Y, Xie Y, Hao Z, Bi H, Liu Y, Yang X
and Xia Y: Protective effect of uric acid on ox-LDL-induced HUVECs
injury via Keap1-Nrf2-ARE pathway. J Immunol Res.
2021(5151168)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ouyang R, Zhao X, Zhang R, Yang J, Li S
and Deng D: FGF21 attenuates high uric acid-induced endoplasmic
reticulum stress, inflammation and vascular endothelial cell
dysfunction by activating Sirt1. Mol Med Rep. 25(35)2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li P, Zhang L, Zhang M, Zhou C and Lin N:
Uric acid enhances PKC-dependent eNOS phosphorylation and mediates
cellular ER stress: A mechanism for uric acid-induced endothelial
dysfunction. Int J Mol Med. 37:989–997. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Huang Z, Hong Q, Zhang X, Xiao W, Wang L,
Cui S, Feng Z, Lv Y, Cai G, Chen X and Wu D: Aldose reductase
mediates endothelial cell dysfunction induced by high uric acid
concentrations. Cell Commun Signal. 15(3)2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lee TS, Lu TM, Chen CH, Guo BC and Hsu CP:
Hyperuricemia induces endothelial dysfunction and accelerates
atherosclerosis by disturbing the asymmetric
dimethylarginine/dimethylarginine dimethylaminotransferase 2
pathway. Redox Biol. 46(102108)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Corry DB, Eslami P, Yamamoto K, Nyby MD,
Makino H and Tuck ML: Uric acid stimulates vascular smooth muscle
cell proliferation and oxidative stress via the vascular
renin-angiotensin system. J Hypertens. 26:269–275. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Doğru S, Yaşar E and Yeşilkaya A: Uric
acid can enhance MAPK pathway-mediated proliferation in rat primary
vascular smooth muscle cells via controlling of mitochondria and
caspase-dependent cell death. J Recept Signal Transduct Res.
42:293–301. 2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Li T, Kon N, Jiang L, Tan M, Ludwig T,
Zhao Y, Baer R and Gu W: Tumor suppression in the absence of
p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell.
149:1269–1283. 2012.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Itahana Y and Itahana K: Emerging roles of
p53 family members in glucose metabolism. Int J Mol Sci.
19(776)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Mercer J and Bennett M: The role of p53 in
atherosclerosis. Cell Cycle. 5:1907–1909. 2006.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Phadwal K, Tang QY, Luijten I, Zhao JF,
Corcoran B, Semple RK, Ganley IG and MacRae VE: p53 regulates
mitochondrial dynamics in vascular smooth muscle cell
calcification. Int J Mol Sci. 24(1643)2023.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Popowich DA, Vavra AK, Walsh CP,
Bhikhapurwala HA, Rossi NB, Jiang Q, Aalami OO and Kibbe MR:
Regulation of reactive oxygen species by p53: Implications for
nitric oxide-mediated apoptosis. Am J Physiol Heart Circ Physiol.
298:H2192–H2200. 2010.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Itahana Y, Han R, Barbier S, Lei Z, Rozen
S and Itahana K: The uric acid transporter SLC2A9 is a direct
target gene of the tumor suppressor p53 contributing to antioxidant
defense. Oncogene. 34:1799–1810. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Kang DH, Han L, Ouyang X, Kahn AM,
Kanellis J, Li P, Feng L, Nakagawa T, Watanabe S, Hosoyamada M, et
al: Uric acid causes vascular smooth muscle cell proliferation by
entering cells via a functional urate transporter. Am J Nephrol.
25:425–433. 2005.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Oğuz N, Kırça M, Çetin A and Yeşilkaya A:
Effect of uric acid on inflammatory COX-2 and ROS pathways in
vascular smooth muscle cells. J Recept Signal Transduct Res.
37:500–505. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Tang L, Xu Y, Wei Y and He X: Uric acid
induces the expression of TNF-α via the ROS-MAPK-NF-κB signaling
pathway in rat vascular smooth muscle cells. Mol Med Rep.
16:6928–6933. 2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
National Research Council: Guide for the
Care and Use of Laboratory Animals: 8th edition. The National
Academies Press, Washington, DC, 2011. https://doi.org/10.17226/12910.
|
|
50
|
American Veterinary Medical Association:
AVMA Guidelines for the Euthanasia of Animals. AVMA, Schaumburg,
IL, 2020. https://www.avma.org/resources-tools/avma-policies/avma-guidelines-euthanasia-animals.
|
|
51
|
Boston University: Institutional animal
care and use committee (IACUC) Guidelines. https://www.bu.edu/research/ethics-compliance/.
|
|
52
|
University of Maryland: Animal care and
use Training. https://research.umd.edu/resources/department-laboratory-animal-resources-dlar/animal-care-and-use-training.
|
|
53
|
Ahmadi-Noorbakhsh S, Abbasi MF, Ghasemi M,
Bayat G, Davoodian N, Sharif-Paghaleh E, Poormoosavi SM, Rafizadeh
M, Maleki M, Shirzad-Aski H, et al: Anesthesia and analgesia for
common research models of adult mice. Lab Anim Res.
38(40)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Parasuraman S and Christapher PV:
Anesthesia and euthanasia of experimental animals. In: Introduction
to basics of pharmacology and toxicology: Volume 3: Experimental
Pharmacology: Research methodology and biostatistics. Springer,
pp65-75, 2022.
|
|
55
|
Gunther S, Alexander RW, Atkinson WJ and
Gimbrone MA Jr: Functional angiotensin II receptors in cultured
vascular smooth muscle cells. J Cell Biol. 92:289–298.
1982.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Görlach A, Brandes RP, Bassus S, Kronemann
N, Kirchmaier CM, Busse R and Schini-Kerth VB: Oxidative stress and
expression of p22phox are involved in the up-regulation of tissue
factor in vascular smooth muscle cells in response to activated
platelets. FASEB J. 14:1518–1528. 2000.PubMed/NCBI
|
|
57
|
Muraoka S and Miura T: Inhibition by uric
acid of free radicals that damage biological molecules. Pharmacol
Toxicol. 93:284–289. 2003.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Rodrigo R, González J and Paoletto F: The
role of oxidative stress in the pathophysiology of hypertension.
Hyperten Res. 34:431–440. 2011.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H,
Jiang J, Xu Y and Lu W: The role of oxidative stress in
hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid
Med Cell Longev. 2021(1470380)2021.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Levine AB, Punihaole D and Levine TB:
Characterization of the role of nitric oxide and its clinical
applications. Cardiology. 122:55–68. 2012.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Napoli C, Paolisso G, Casamassimi A,
Al-Omran M, Barbieri M, Sommese L, Infante T and Ignarro LJ:
Effects of nitric oxide on cell proliferation: Novel insights. J Am
Coll Cardiol. 62:89–95. 2013.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Gherghina ME, Peride I, Tiglis M, Neagu
TP, Niculae A and Checherita IA: Uric acid and oxidative
stress-relationship with cardiovascular, metabolic, and renal
impairment. Int J Mol Sci. 23(3188)2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Li M, Qian M, Kyler K and Xu J:
Endothelial-vascular smooth muscle cells interactions in
atherosclerosis. Front Cardiovasc Med. 5(151)2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Hirase T and Node K: Endothelial
dysfunction as a cellular mechanism for vascular failure. Am J
Physiol Heart Circ Physiol. 302:H499–H505. 2012.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Vanhoutte PM, Zhao Y, Xu A and Leung SW:
Thirty years of saying NO: Sources, fate, actions, and misfortunes
of the endothelium-derived vasodilator mediator. Circ Res.
119:375–396. 2016.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Tsutsui H, Kinugawa S and Matsushima S:
Oxidative stress and heart failure. Am J Physiol Heart Circ
Physiol. 30:H2181–H2190. 2011.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Sugamura K and Keaney JF Jr: Reactive
oxygen species in cardiovascular disease. Free Radic Biol Med.
51:978–992. 2011.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Drummond GR, Selemidis S, Griendling KK
and Sobey CG: Combating oxidative stress in vascular disease: NADPH
oxidases as therapeutic targets. Nat Rev Drug Discov. 10:453–471.
2011.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Murray M, Selby-Pham S, Colton BL, Bennett
L, Williamson G and Dordevic AL: Does timing of phytonutrient
intake influence the suppression of postprandial oxidative stress?
A systematic literature review. Redox Biol.
46(102123)2021.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Baradaran A, Nasri H and Rafieian-Kopaei
M: Oxidative stress and hypertension: Possibility of hypertension
therapy with antioxidants. J Res Med Sci. 19:358–367.
2014.PubMed/NCBI
|
|
71
|
Tahhan AS, Sandesara PB, Hayek SS,
Alkhoder A, Chivukula K, Hammadah M, Mohamed-Kelli H, O'Neal WT,
Topel M, Ghasemzadeh N, et al: Association between oxidative stress
and atrial fibrillation. Heart Rhythm. 14:1849–1855.
2017.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Ahmad KA, Yuan DY, Nawaz W, Ze H, Zhuo CX,
Talal B, Taleb A, Mais E and Qilong D: Antioxidant therapy for
management of oxidative stress induced hypertension. Free Radic
Res. 51:428–438. 2017.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Kattoor AJ, Pothineni NVK, Palagiri D and
Mehta JL: Oxidative stress in atherosclerosis. Curr Atheroscler
Rep. 19(42)2017.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Dai Y, Cao Y, Zhang Z, Vallurupalli S and
Mehta JL: Xanthine oxidase induces foam cell formation through
LOX-1 and NLRP3 activation. Cardiovasc Drugs Ther. 31:19–27.
2017.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Coliva G, Lange M, Colombo S, Chervet JP,
Domingues MR and Fedorova M: Sphingomyelins prevent propagation of
lipid peroxidation-LC-MS/MS evaluation of inhibition mechanisms.
Molecules. 25(1925)2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Chan HH, Chan E, Kwok CTK, Leung GPH, Lee
SMY and Seto SW: The role of p53 in the alternation of vascular
functions. Front Pharmacol. 13(981152)2022.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Mercer J, Figg N, Stoneman V, Braganza D
and Bennett MR: Endogenous p53 protects vascular smooth muscle
cells from apoptosis and reduces atherosclerosis in ApoE knockout
mice. Circ Res. 96:667–674. 2005.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Cao RY, Eves R, Jia L, Funk CD, Jia Z and
Mak AS: Effects of p53-knockout in vascular smooth muscle cells on
atherosclerosis in mice. PLoS One. 12(e0175061)2017.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Wang M and Attardi LD: A balancing act:
p53 activity from tumor suppression to pathology and therapeutic
implications. Annu Rev Pathol. 17:205–226. 2022.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Kastenhuber ER and Lowe SW: Putting p53 in
context. Cell. 170:1062–1078. 2017.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Buizza L, Cenini G, Lanni C,
Ferrari-Toninelli G, Prandelli C, Govoni S, Buoso E, Racchi M,
Barcikowska M, Styczynska M, et al: Conformational altered p53 as
an early marker of oxidative stress in Alzheimer's disease. PLoS
One. 7(e29789)2012.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Yang L, Chang B, Guo Y, Wu X and Liu L:
The role of oxidative stress-mediated apoptosis in the pathogenesis
of uric acid nephropathy. Ren Fail. 41:616–622. 2019.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Liu Y and Gu W: The complexity of
p53-mediated metabolic regulation in tumor suppression. Semin
Cancer Biol. 85:4–32. 2022.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Kruiswijk F, Labuschagne CF and Vousden
KH: p53 in survival, death and metabolic health: A lifeguard with a
licence to kill. Nat Rev Mol Cell Biol. 16:393–405. 2015.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Kibbe MR, Li J, Nie S, Choi BM, Kovesdi I,
Lizonova A, Billiar TR and Tzeng E: Potentiation of nitric
oxide-induced apoptosis in p53-/- vascular smooth muscle cells. Am
J Physiol Cell Physiol. 282:C625–C634. 2002.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Kim YM, Choi BM, Kim YS, Kwon YG, Kibbe
MR, Billiar TR and Tzeng E: Protective effect of p53 in vascular
smooth muscle cells against nitric oxide-induced apoptosis is
mediated by up-regulation of heme oxygenase-2. BMB Rep. 41:164–169.
2008.PubMed/NCBI View Article : Google Scholar
|
